Rheumatology drugs
3 results
Saphnelo (anifrolumab-fnia)
(Anifrolumab-fnia)AstraZeneca Pharmaceuticals LP
Usage: SAPHNELO (anifrolumab-fnia) is indicated for treating adult patients with moderate to severe systemic lupus erythematosus (SLE) alongside standard therapy. Its use is not recommended for patients with severe active lupus nephritis or severe central nervous system lupus due to unproven efficacy in those conditions.
Tymlos (abaloparatide)
(abaloparatide)Radius Health, Inc.
Usage: TYMLOS is indicated for the treatment of postmenopausal women and men with osteoporosis at high risk for fractures, including those with a history of osteoporotic fractures or those intolerant to other therapies. It reduces the risk of vertebral and nonvertebral fractures and increases bone density.
Zilretta (triamcinolone acetonide extended-release injectable suspension)
(triamcinolone acetonide extended-release injectable suspension)Pacira Pharmaceuticals, Inc.
Usage: ZILRETTA (triamcinolone acetonide extended-release injectable suspension) is indicated for intra-articular injection to manage osteoarthritis pain of the knee. The safety and efficacy of repeat administrations have not been established.